InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-0.5%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Lee Tom Y, Chief Executive Officer. Insider active across 1 company, notably Pure Bioscience, INC.. Cumulatively, 5 filings have been logged. Split: 4 buys · 0 sell. Total volume traded: €35k. History available since 16 June 2021. The latest transaction was disclosed on 15 December 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
50,000 shares@ US$0.1310.3% of flowCommon StockSEC:0001209191-22-062029:0
Ideal exit: 11 Sept 2023 (T+270)
15,741,666 shares@ US$0.1598.5% of flowCommon StockSEC:0001209191-22-042561:0
21,227 shares@ US$0.180.044% mcap11.9% of flowCommon StockSEC:0001209191-22-020677:0
Ideal exit: 11 Dec 2022 (T+270)
35,998 shares@ US$0.4310.5% of flowCommon StockSEC:0001209191-21-042593
Ideal exit: 13 Mar 2022 (T+270)
35,998 shares@ US$0.4310.17% mcap44.1% of flowCommon StockSEC:0001209191-21-042593:0
Ideal exit: 13 Mar 2022 (T+270)
5 of 5 declarations
About Lee Tom Y
Tom Y Lee is the Chief Executive Officer of PURE BIOSCIENCE, INC. He is responsible for the strategic and operational direction of the company. His leadership and expertise in the bioscience sector are essential in guiding PURE BIOSCIENCE, INC. towards its growth objectives.
